Nyrada
Menu
NYR:
Market Cap*:
Price Delay ~20min
Home
About Us
Company Overview
Board of Directors
Management
Scientific Advisory Board
Corporate Governance
Our Science
Lead Drug Development
Brain Injury Program
Cholesterol Lowering Program
Technical Glossary
Drug Development Pathway
Investors
Investor Welcome
ASX Announcements
Brain Injury Program
Cholesterol-Lowering Program
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Key Dates
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Extraordinary General Meeting
Past Shareholder Meetings
News & Insights
Presentations & Interviews
Media
Newsletters
Publications
Contact Us
Contact Us
Working at Nyrada
Email Alerts
News & Insights
Home
>
News & Insights
>
Presentations & Interviews
Presentations & Interviews
Media
Newsletters
Publications
Presentations & Interviews
18-Apr-2024
3QFY2024 Results and Investor Conference Call Video
11-Apr-2024
Nyrada CEO James Bonner and SAB Chair Gary Housley interview with Proactive Investors
28-Feb-2024
Nyrada CEO James Bonner interview with 180 Markets
28-Feb-2024
Nyrada CEO James Bonner interview with Financial News Network
5-Dec-2022
James Bonnar (CEO) speaks to Tony Locantro (Alto Capital) about Nyrada’s Phase I Cholesterol Lowering Study
29-Sep-2022
Nyrada (ASX:NYR) CEO, James Bonnar presentation to ShareCafe’s Hidden Gems Webinar, September 2022
29-Sep-2022
Presentation to ShareCafe Hidden Gems Webinar
5-Sep-2022
Presentation to E&P Small Caps Health Care Conference
7-Jun-2022
Corporate Presentation
30-Mar-2022
Investor Roadshow Presentation
2-Mar-2022
Presentation to Meet the CEO Life Sciences Edition
14-Sep-2021
Nyrada (ASX:NYR) CEO, James Bonnar presents at the ASX Small and Mid-Cap Conference
14-Sep-2021
Nyrada (NYR: ASX) CEO, James Bonnar interview with Andrew Scott (Proactive Investors) at the ASX Small and Mid-Cap Conference, September 2021
1-Jul-2021
Nyrada (ASX:NYR) interview with Finance News Network, June 2021
23-Feb-2021
Nyrada (ASX:NYR) CEO, James Bonnar provides update on lead drug development programs at Finance News Network CEO Showcase, February 2021
3-Feb-2021
Nyrada (ASX:NYR) discusses collaboration with the Walter Reed Army Institute of Research and UNSW Sydney, February 2021
6-Jan-2021
Nyrada (ASX:NYR) discusses progress in cholesterol-lowering drug program, January 2021
19-Nov-2020
Presentation to 2020 Annual General Meeting of Shareholders
17-Nov-2020
Pitt Street Research Interview with Nyrada CEO, Mr James Bonnar
11-Sep-2020
Nyrada Inc - Hidden Gems Webinar Presentation
11-Aug-2020
Nyrada July/August 2020 webinar recording: New Therapies for Cardiovascular and Neurological Diseases, August 2020
23-Jul-2020
Nyrada Roadshow Corporate Presentation July/August 2020
24-Jun-2020
Nyrada presents at the Reach Markets "Meet the CEO's" virtual event June 24, 2020
30-Apr-2020
Nyrada Virtual Investor Event 30 April 2020
30-Apr-2020
Nyrada Preclinical Program & Corporate Update Presentation
27-Feb-2020
Nyrada Inc. Corporate Presentation February 2020
23-Jan-2020
Nyrada (ASX:NYR) - new therapies for cardiovascular and neurological disorders
17-Jan-2020
Nyrada Inc - Corporate Presentation
14-Aug-2019
Nyrada (ASX:NYR) targeting cholesterol-lowering drug candidate
